28 results on '"Ahmed, Muhammad Bilal"'
Search Results
2. Smart Virtual Product Development (SVPD) to Enhance Product Manufacturing in Industry 4.0
- Author
-
Ahmed, Muhammad Bilal, Sanin, Cesar, and Szczerbicki, Edward
- Published
- 2019
- Full Text
- View/download PDF
3. Design and Development of Ti3C2 Tx MXenes as Cathode Materials for Energy Storage Devices.
- Author
-
Ahmed, Muhammad Bilal, Butt, Faaz Ahmed, Naqvi, Asad A., Asad, Samra, ul Hussain Awan, Zahoor, Shahid, Zain, and Khan, Tayyab Azad
- Abstract
The highly conductive property of Titanium Carbide MXene (Ti
3 C2 Tx ) MXenes has made them an area of research in the electrochemical field. However, their properties are subjected to their correct synthesis. Various synthesis methods have been reported; however, those methods employ high energy consumption. To reduce the cost, researchers have tried to synthesize using inexpensive precursors; however, fewer have resorted to the use of an alternative technique. This study employed the use of the tungsten inert gas welding process to synthesize the Ti3 AlC2 MAX phase, which was later etched using the in situ hydrogen fluoride acid technique. Alternatively, another MAX phase was prepared using an atmosphere furnace under the purging of argon gas. However, impurities were detected in the MAX phase and later detected in titanium powder. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation.
- Author
-
Ahmed, Muhammad Bilal, Islam, Salman Ul, Alghamdi, Abdullah A. A., Kamran, Muhammad, Ahsan, Haseeb, and Lee, Young Sup
- Subjects
- *
CAMPTOTHECIN , *THERAPEUTICS , *METASTASIS , *NON-communicable diseases , *PHYTOCHEMICALS , *CANCER chemoprevention - Abstract
Cancer is one of the deadliest non communicable diseases. Numerous anticancer medications have been developed to target the molecular pathways driving cancer. However, there has been no discernible increase in the overall survival rate in cancer patients. Therefore, innovative chemo-preventive techniques and agents are required to supplement standard cancer treatments and boost their efficacy. Fruits and vegetables should be tapped into as a source of compounds that can serve as cancer therapy. Phytochemicals play an important role as sources of new medication in cancer treatment. Some synthetic and natural chemicals are effective for cancer chemoprevention, i.e., the use of exogenous medicine to inhibit or impede tumor development. They help regulate molecular pathways linked to the development and spread of cancer. They can enhance antioxidant status, inactivating carcinogens, suppressing proliferation, inducing cell cycle arrest and death, and regulating the immune system. While focusing on four main categories of plant-based anticancer agents, i.e., epipodophyllotoxin, camptothecin derivatives, taxane diterpenoids, and vinca alkaloids and their mode of action, we review the anticancer effects of phytochemicals, like quercetin, curcumin, piperine, epigallocatechin gallate (EGCG), and gingerol. We examine the different signaling pathways associated with cancer and how inflammation as a key mechanism is linked to cancer growth. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Assessment of Nutritional Status of Patients on the Maintenance Hemodialysis at Tertiary Care Hospital using Malnutrition Inflammatory Score.
- Author
-
Bin Tahir, Hasham, Khan, Malik Nadeem Azam, Tariq, Rabia, Khan, Raheel, Ahmed, Muhammad Bilal, and Khan, Hafiz Waleed
- Subjects
NUTRITIONAL assessment ,CHRONIC kidney failure ,HEMODIALYSIS patients ,HOSPITAL utilization ,MYOCARDIAL ischemia - Abstract
Objective: To determine the frequency of protein energy wasting among end stage renal disease patients on maintenance hemodialysis. Study Design: Cross-sectional analytical study. Place and Duration of Study: Department of Nephrology, Pak Emirates Military Hospital, Rawalpindi Pakistan, from May 2019 to Mar 2020. Methodology: Two hundered patients diagnosed with end-stage renal disease on maintenance hemodialysis were included in the study. Protein-energy wasting was assessed using the Malnutrition inflammatory score comprising four x components: medical history, physical examination, laboratory parameters and body mass index. Malnutrition inflammatory score was used to categorize protein-energy wasting. Results: Out of 200 patients with ESRD on maintenance hemodialysis, 73(36.5%) patients had mild, 120(60.0 %) patients had moderate, and 7(3.5%) patients had severe protein-energy wasting. The advanced age group, multiple comorbid (diabetes mellitus, hypertension, ischemic heart disease), and duration of hemodialysis (> 2 years) had a statistically significant association with the protein energy wasting (p-value < 0.05). Protein-energy wasting was also more prevalent in patients with low monthly income (p-value 0.04). Conclusion: Protein-energy wasting is common among patients with end stage renal disease on maintenance hemodialysis. Old age group, multiple comorbid, and duration of hemodialysis are important risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Endophyte-Mediated Stress Tolerance in Plants: A Sustainable Strategy to Enhance Resilience and Assist Crop Improvement.
- Author
-
Kamran, Muhammad, Imran, Qari Muhammad, Ahmed, Muhammad Bilal, Falak, Noreen, Khatoon, Amna, and Yun, Byung-Wook
- Subjects
CROP improvement ,PLANT-microbe relationships ,ABIOTIC stress ,SOIL fertility ,PLANT protection ,PESTICIDES - Abstract
Biotic and abiotic stresses severely affect agriculture by affecting crop productivity, soil fertility, and health. These stresses may have significant financial repercussions, necessitating a practical, cost-effective, and ecologically friendly approach to lessen their negative impacts on plants. Several agrochemicals, such as fertilizers, pesticides, and insecticides, are used to improve plant health and protection; however, these chemical supplements have serious implications for human health. Plants being sessile cannot move or escape to avoid stress. Therefore, they have evolved to develop highly beneficial interactions with endophytes. The targeted use of beneficial plant endophytes and their role in combating biotic and abiotic stresses are gaining attention. Therefore, it is important to experimentally validate these interactions and determine how they affect plant fitness. This review highlights research that sheds light on how endophytes help plants tolerate biotic and abiotic stresses through plant–symbiont and plant–microbiota interactions. There is a great need to focus research efforts on this vital area to achieve a system-level understanding of plant–microbe interactions that occur naturally. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Role of Nrf2, STAT3, and Src as Molecular Targets for Cancer Chemoprevention.
- Author
-
Ahsan, Haseeb, Islam, Salman Ul, Ahmed, Muhammad Bilal, and Lee, Young Sup
- Subjects
CANCER chemoprevention ,STAT proteins ,DRUG target ,NUCLEAR factor E2 related factor ,ONCOGENES ,DIRECT action ,CELL migration - Abstract
Cancer is a complex and multistage disease that affects various intracellular pathways, leading to rapid cell proliferation, angiogenesis, cell motility, and migration, supported by antiapoptotic mechanisms. Chemoprevention is a new strategy to counteract cancer; to either prevent its incidence or suppress its progression. In this strategy, chemopreventive agents target molecules involved in multiple pathways of cancer initiation and progression. Nrf2, STAT3, and Src are promising molecular candidates that could be targeted for chemoprevention. Nrf2 is involved in the expression of antioxidant and phase II metabolizing enzymes, which have direct antiproliferative action as well as indirect activities of reducing oxidative stress and eliminating carcinogens. Similarly, its cross-talk with NF-κB has great anti-inflammatory potential, which can be utilized in inflammation-induced/associated cancers. STAT3, on the other hand, is involved in multiple pathways of cancer initiation and progression. Activation, phosphorylation, dimerization, and nuclear translocation are associated with tumor cell proliferation and angiogenesis. Src, being the first oncogene to be discovered, is important due to its convergence with many upstream stimuli, its cross-talk with other potential molecular targets, such as STAT3, and its ability to modify the cell cytoskeleton, making it important in cancer invasion and metastasis. Therefore, the development of natural/synthetic molecules and/or design of a regimen that can reduce oxidative stress and inflammation in the tumor microenvironment and stop multiple cellular targets in cancer to stop its initiation or retard its progression can form newer chemopreventive agents. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.
- Author
-
Ahmed, Muhammad Bilal, Alghamdi, Abdullah A. A., Islam, Salman Ul, Lee, Joon-Seok, and Lee, Young-Sup
- Subjects
- *
CYCLIC adenylic acid , *TUMOR microenvironment , *TUMOR growth , *PROTEIN kinases , *CARCINOGENESIS , *CYCLIC-AMP-dependent protein kinase - Abstract
Cancer is one of the most common causes of death globally. Despite extensive research and considerable advances in cancer therapy, the fundamentals of the disease remain unclear. Understanding the key signaling mechanisms that cause cancer cell malignancy may help to uncover new pharmaco-targets. Cyclic adenosine monophosphate (cAMP) regulates various biological functions, including those in malignant cells. Understanding intracellular second messenger pathways is crucial for identifying downstream proteins involved in cancer growth and development. cAMP regulates cell signaling and a variety of physiological and pathological activities. There may be an impact on gene transcription from protein kinase A (PKA) as well as its downstream effectors, such as cAMP response element-binding protein (CREB). The position of CREB downstream of numerous growth signaling pathways implies its oncogenic potential in tumor cells. Tumor growth is associated with increased CREB expression and activation. PKA can be used as both an onco-drug target and a biomarker to find, identify, and stage tumors. Exploring cAMP effectors and their downstream pathways in cancer has become easier using exchange protein directly activated by cAMP (EPAC) modulators. This signaling system may inhibit or accelerate tumor growth depending on the tumor and its environment. As cAMP and its effectors are critical for cancer development, targeting them may be a useful cancer treatment strategy. Moreover, by reviewing the material from a distinct viewpoint, this review aims to give a knowledge of the impact of the cAMP signaling pathway and the related effectors on cancer incidence and development. These innovative insights seek to encourage the development of novel treatment techniques and new approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Smart Virtual Product Development: Manufacturing Capability Analysis and Process Planning Module.
- Author
-
Ahmed, Muhammad Bilal, Sanin, Cesar, and Szczerbicki, Edward
- Subjects
- *
PROCESS capability , *PRODUCTION planning , *NEW product development , *MANUFACTURING processes , *INDUSTRY 4.0 , *KEY performance indicators (Management) - Abstract
Smart Virtual Product Development (SVPD) system provides effective use of information, knowledge, and experience in industry during the process of product development in Industry 4.0 scenario. This system comprises of three primary modules, each of which has been developed to cater to a need for digital knowledge capture for smart manufacturing in the areas of product design, production planning, and inspection planning. Manufacturing Capability Analysis and Process Planning (MCAPP) module is an important module of the SVPD system, and it involves the provision of manufacturing knowledge to experts working on product development at the early stages of the product lifecycle. In this research, we firstly describe the structure and working mechanism of the SVPD system's MCAPP module. This is followed by validation of the MCAPP module's Manufacturing Process Planning (MPP) sub-module against the key performance indicators (KPIs) by using our threading tap case study. Our results verify the feasibility of our approach and show how manufacturing knowledge relating to features and functions can be used to enhance the manufacturing process across similar products during the early stages of product development. An analysis of the basic concepts and methods of implementation show that this is an expert system capable of supporting smart manufacturing which can play a vital role in the establishment of Industry 4.0. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. PRP4 Induces Epithelial–Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53.
- Author
-
Islam, Salman Ul, Ahmed, Muhammad Bilal, Sonn, Jong-Kyung, Jin, Eun-Jung, and Lee, Young-Sup
- Subjects
- *
DRUG resistance in cancer cells , *CYCLIN-dependent kinases , *EPITHELIAL-mesenchymal transition , *MITOGEN-activated protein kinases , *CARCINOGENS - Abstract
Pre-mRNA processing factor 4B (PRP4) promotes pre-mRNA splicing and signal transduction. Recent studies have shown that PRP4 modulates the assembly of actin cytoskeleton in cancer cells and induces epithelial–mesenchymal transition (EMT) and drug resistance. PRP4 displays kinase domain-like cyclin-dependent kinases and mitogen-activated protein kinases, making it capable of phosphorylating p53 and other target proteins. In the current study, we report that PRP4 induces drug resistance and EMT via direct binding to the p53 protein, inducing its phosphorylation. Moreover, PRP4 overexpression activates the transcription of miR-210 in a hypoxia-inducible factor 1α (HIF-1α)-dependent manner, which activates p53. The involvement of miR-210 in the activation of p53 was confirmed by utilizing si-miR210. si-miR210 blocked the PRP4-activated cell survival pathways and reversed the PRP4-induced EMT phenotype. Moreover, we used deferoxamine as a hypoxia-mimetic agent, and si-HIF to silence HIF-1α. This procedure demonstrated that PRP4-induced EMT and drug resistance emerged in response to consecutive activation of HIF-1α, miR-210, and p53 by PRP4 overexpression. Collectively, our findings suggest that the PRP4 contributes to EMT and drug resistance induction via direct interactions with p53 and actions that promote upregulation of HIF-1α and miR-210. We conclude that PRP4 is an essential factor promoting cancer development and progression. Specific PRP4 inhibition could benefit patients with colon cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Experience-Based Product Inspection Planning for Industry 4.0.
- Author
-
Ahmed, Muhammad Bilal, Majeed, Farhat, Sanin, Cesar, and Szczerbicki, Edward
- Subjects
- *
NEW product development , *INDUSTRY 4.0 , *MANUFACTURING processes , *PRODUCTION planning , *KNOWLEDGE management - Abstract
In this paper we describe how our Smart Virtual Product Development (SVPD) system can be used to enhance product inspection planning. The SVPD system is comprised of three main modules, these being the design knowledge management (DKM) module, the manufacturing capability and process planning (MCAPP) module, and the product inspection planning (PIP) module. Experiential knowledge relating to formal decisional events is collected, stored and used by the system in the form of set of experiences (SOEs). Here we discuss the working mechanism of the PIP module and show how experiential knowledge relating to the inspection of products that have features and functions in common can be used to enhance product inspection planning during early stages of product development. Our discussion commences with an introduction to fundamental concepts and a general system overview. We then describe the development of our SVPD system's PIP module, and a case study we undertook for validation purposes. Results of the case study show that our system is capable of supporting product inspection planning in smart manufacturing, and thus has a vital role to play in Industry 4.0. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Decursin negatively regulates LPS-induced upregulation of the TLR4 and JNK signaling stimulated by the expression of PRP4 in vitro.
- Author
-
Ahmed, Muhammad Bilal, Islam, Salman Ul, and Lee, Young Sup
- Subjects
- *
CELL morphology , *SKIN cancer , *CYTOSKELETON , *PATHOLOGY , *COLON cancer , *MACROPHAGE inflammatory proteins , *LIPOPOLYSACCHARIDES - Abstract
The current investigation was carried out to analyze the correlation of bacterial lipopolysaccharide (LPS) and pre-mRNA processing factor 4B (PRP4) in inducing inflammatory response and cell actin cytoskeleton rearrangement in macrophages (Raw 264.7) and colorectal (HCT116) as well as skin cancer (B16-F10) cells. Cell lines were stimulated with LPS, and the expression of PRP4 as well as pro-inflammatory cytokines and proteins like IL-6, IL-1β, TLR4, and NF-κB were assayed. The results demonstrated that LPS markedly increased the expression of PRP4, IL-6, IL-1β, TLR4, and NF-κB in the cells. LPS and PRP4 concomitantly altered the morphology of cells from an aggregated, flattened shape to a round shape. Decursin, a pyranocoumarin from Angelica gigas, inhibited the LPS and PRP4-induced inflammatory response, and reversed the induction of morphological changes. Finally, we established a possible link of LPS with TLR4 and JNK signaling, through which it activated PRP4. Our study provides molecular insights for LPS and PRP4-related pathogenesis and a basis for developing new strategies against metastasis in colorectal cancer and skin melanoma. Our study emphasizes that decursin may be an effective treatment strategy for various cancers in which LPS and PRP4 perform a critical role in inducing inflammatory response and morphological changes leading to cell survival and protection against anti-cancer drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Enhancing Product Manufacturing through Smart Virtual Product Development (SVPD) for Industry 4.0.
- Author
-
Ahmed, Muhammad Bilal, Majeed, Farhat, Sanin, Cesar, and Szczerbicki, Edward
- Subjects
- *
MANUFACTURED products , *NEW product development , *INDUSTRY 4.0 , *MANUFACTURING processes , *PRODUCTION planning - Abstract
This paper proposes the Smart Virtual Product Development (SVPD) system, which enhances the industrial product manufacturing processes. The proposed system comprises of three main modules: design knowledge management (DKM), manufacturing capability analysis and process planning (MCAPP), and product inspection planning (PIP). Smart virtual product development system collects, stores, and uses experiential knowledge from formal decisional events in the form of set of experience (SOE). This research explains the working mechanism of MCAPP module, and shows how manufacturing knowledge of similar products having some common features and functions is used to enrich the manufacturing process. First, the basic description and principles of the approach are introduced, then the prototype version of the system is developed and tested for manufacturing capability and process planning (MCAPP) module for the case study, which verifies the feasibility of the proposed approach. The presented system successfully supports smart manufacturing, and can play a vital role in Industry 4.0. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Methanolic Extract of Artemia salina Eggs and Various Fractions in Different Solvents Contain Potent Compounds That Decrease Cell Viability of Colon and Skin Cancer Cell Lines and Show Antibacterial Activity against Pseudomonas aeruginosa.
- Author
-
Islam, Salman Ul, Ahmed, Muhammad Bilal, Shehzad, Adeeb, and Lee, Young Sup
- Subjects
- *
EGGS , *ANIMAL experimentation , *ANTIBIOTICS , *ANTINEOPLASTIC agents , *CELL death , *CELL lines , *ANALYTICAL chemistry , *ANALYTICAL chemistry techniques , *COLON tumors , *COLORIMETRY , *CRUSTACEA , *FLOW cytometry , *GAS chromatography , *MASS spectrometry , *MELANOMA , *METHANOL , *MOLECULAR structure , *ORGANIC compounds , *PSEUDOMONAS diseases , *WESTERN immunoblotting , *CELL survival ,RECTUM tumors - Abstract
Artemia salina, crustaceans of class Branchiopoda and order Anostraca, are living and reproducing only in highly saline natural lakes and in other reservoirs where sea water is evaporated to produce salt. Artemia salina eggs can be purchased from pet stores, where they are sold as tropical fish food and a ready source for hatching shrimp. In the current study, methanolic crude extracts and various fractions of Artemia salina eggs extracted in other solvents were tested for effects on cell viability of human colorectal cancer cells (HCT116) and melanoma cells (B16F10) using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. A methanolic crude extract of eggs was obtained by cold maceration, followed by fractionation to obtain hexane, chloroform, ethyl acetate, n-butanol, and aqueous fractions. The methanolic crude extract decreased cell viability of HCT-116 and B16F10 cell lines at higher concentrations. The other fractions were evaluated using a cell viability assay, and chloroform and hexane showed the highest activity at significantly lower concentrations than did the methanolic fraction. Full scan profiles of the methanolic crude extract and the chloroform and hexane fractions were obtained by gas chromatography mass spectrometry (GC-MS), and the resultant compounds were identified by comparing their spectral data to those available in spectral matching libraries. ROS generation assay, flow cytometry, and western blot analysis provided supporting evidence that the hexane and chloroform fractions induced cell death in HCT116 and B16-F10 cell lines. All fractions were further tested for antibacterial activity against Pseudomonas aeruginosa, among which the hexane fraction showed the highest zone of inhibition on LB nutrient agar plates. This study demonstrated promising anticancer and antibacterial effects of Artemia salina egg extracts. Our results suggest that pure bioactive compounds obtained from Artemia salina eggs can provide new insights into the mechanisms of colon and skin cancer, as well as Pseudomonas aeruginosa inhibition. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
- Author
-
Islam, Salman Ul, Ahmed, Muhammad Bilal, Lee, Su Jin, Shehzad, Adeeb, Sonn, Jong Kyung, Kwon, Oh-Shin, and Lee, Young Sup
- Subjects
- *
CYTOSKELETON formation , *PROTEIN kinases , *CANCER cells , *EPITHELIAL cells , *MESENCHYMAL stem cells - Abstract
Cell actin cytoskeleton is primarily modulated by Rho family proteins. RhoA regulates several downstream targets, including Rho-associated protein kinase (ROCK), LIM-Kinase (LIMK), and cofilin. Pre-mRNA processing factor 4B (PRP4) modulates the actin cytoskeleton of cancer cells via RhoA activity inhibition. In this study, we discovered that PRP4 over-expression in HCT116 colon cancer cells induces cofilin dephosphorylation by inhibiting the Rho-ROCK-LIMK-cofilin pathway. Two-dimensional gel electrophoresis, and matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry (MALDI-TOF MS) analysis indicated increased expression of protein phosphatase 1A (PP1A) in PRP4-transfected HCT116 cells. The presence of PRP4 increased the expression of PP1A both at the mRNA and protein levels, which possibly activated cofilin through dephosphorylation and subsequently modulated the cell actin cytoskeleton. Furthermore, we found that PRP4 over-expression did not induce cofilin dephosphorylation in the presence of okadaic acid, a potent phosphatase inhibitor. Moreover, we discovered that PRP4 over-expression in HCT116 cells induced dephosphorylation of migration and invasion inhibitory protein (MIIP), and down-regulation of E-cadherin protein levels, which were further restored by the presence of okadaic acid. These findings indicate a possible molecular mechanism of PRP4-induced actin cytoskeleton remodeling and epithelial-mesenchymal transition, and make PRP4 an important target in colon cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
16. Experience-Based Decisional DNA (DDNA) to Support Product Development.
- Author
-
Ahmed, Muhammad Bilal, Sanin, Cesar, and Szczerbicki, Edward
- Subjects
- *
NEW product development , *MARKETING , *PRODUCT management , *MANUFACTURED products , *COMMUNICATION - Abstract
Knowledge and experience are important requirements for product development. The aim of this paper is to propose a systematic approach for industrial product development. This approach uses smart knowledge management system comprising of set of experience knowledge structure and decisional DNA (DDNA) along with virtual engineering tools (virtual engineering object, virtual engineering process, and virtual engineering factory). This system provides a new direction to researchers working on product development, especially designers and manufacturers. It will reduce their communication gap by allowing them to work on the same platform. The proposed system adopts an early consideration of manufacturing issues. Therefore, it can shorten product development cycle time, minimize overall development cost, and ensure a smooth transition into production. The proposed system is dynamic in nature because it updates itself after every time a new decision related to product development activity is made. Product development process can be performed systematically and efficiently using this system as it stores knowledge of experiences of different activities. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. Assessment of Nutritional Status of Patients on the Maintenance Hemodialysis at Tertiary Care Hospital using Malnutrition Inflammatory Score.
- Author
-
Tahir, Hasham Bin, Khan, Malik Nadeem Azam, Tariq, Rabia, Khan, Raheel, Ahmed, Muhammad Bilal, and Khan, Hafiz Waleed
- Subjects
NUTRITIONAL assessment ,CHRONIC kidney failure ,HEMODIALYSIS patients ,HOSPITAL utilization ,MYOCARDIAL ischemia - Abstract
Objective: To determine the frequency of protein energy wasting among end stage renal disease patients on maintenance hemodialysis. Study Design: Cross-sectional analytical study. Place and Duration of Study: Department of Nephrology, Pak Emirates Military Hospital, Rawalpindi Pakistan, from May 2019 to Mar 2020. Methodology: Two hundered patients diagnosed with end-stage renal disease on maintenance hemodialysis were included in the study. Protein-energy wasting was assessed using the Malnutrition inflammatory score comprising four x components: medical history, physical examination, laboratory parameters and body mass index. Malnutrition inflammatory score was used to categorize protein-energy wasting. Results: Out of 200 patients with ESRD on maintenance hemodialysis, 73(36.5%) patients had mild, 120(60.0%) patients had moderate, and 7(3.5%) patients had severe protein-energy wasting. The advanced age group, multiple comorbid (diabetes mellitus, hypertension, ischemic heart disease), and duration of hemodialysis (> 2 years) had a statistically significant association with the protein energy wasting (p-value < 0.05). Protein-energy wasting was also more prevalent in patients with low monthly income (p-value 0.04). Conclusion: Protein-energy wasting is common among patients with end stage renal disease on maintenance hemodialysis. Old age group, multiple comorbid, and duration of hemodialysis are important risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. PRP4 Promotes Skin Cancer by Inhibiting Production of Melanin, Blocking Influx of Extracellular Calcium, and Remodeling Cell Actin Cytoskeleton.
- Author
-
Ahmed, Muhammad Bilal, Islam, Salman Ul, and Lee, Young Sup
- Subjects
- *
TRP channels , *CYTOSKELETON , *DRUG resistance in cancer cells , *MELANINS , *SKIN cancer , *CALCIUM-sensing receptors - Abstract
Pre-mRNA processing factor 4B (PRP4) has previously been shown to induce epithelial-mesenchymal transition (EMT) and drug resistance in cancer cell lines. As melanin plays an important photoprotective role in the risk of sun-induced skin cancers, we have investigated whether PRP4 can induce drug resistance and regulate melanin biosynthesis in a murine melanoma (B16F10) cell line. Cells were incubated with a crucial melanogenesis stimulator, alpha-melanocyte-stimulating hormone, followed by transfection with PRP4. This resulted in the inhibition of the production of melanin via the downregulation of adenylyl cyclase-cyclic adenosine 3′,5′-monophosphate (AC)–(cAMP)–tyrosinase synthesis signaling pathway. Inhibition of melanin production by PRP4 leads to the promotion of carcinogenesis and induced drug resistance in B16F10 cells. Additionally, PRP4 overexpression upregulated the expression of β-arrestin 1 and desensitized the extracellular calcium-sensing receptor (CaSR), which in turn, inhibited the influx of extracellular Ca2+ ions. The decreased influx of Ca2+ was confirmed by a decreased expression level of calmodulin. We have demonstrated that transient receptor potential cation channel subfamily C member 1 was involved in the influx of CaSR-induced Ca2+ via a decreasing level of its expression. Furthermore, PRP4 overexpression downregulated the expression of AC, decreased the synthesis of cAMP, and modulated the actin cytoskeleton by inhibiting the expression of Ras homolog family member A (RhoA). Our investigation suggests that PRP4 inhibits the production of melanin in B16F10 cells, blocks the influx of Ca2+ through desensitization of CaSR, and modulates the actin cytoskeleton through downregulating the AC–cAMP pathway; taken together, these observations collectively lead to the promotion of skin carcinogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease.
- Author
-
Islam, Salman Ul, Ahmed, Muhammad Bilal, Ahsan, Haseeb, Lee, Young-Sup, Dini, Irene, and Montesano, Domenico
- Subjects
CARDIOVASCULAR diseases ,LDL cholesterol ,NUTS ,LIPID metabolism ,PHYTOCHEMICALS ,PEAS ,VEGANISM - Abstract
Abnormal lipid metabolism leads to the development of hyperlipidemia, a common cause of multiple chronic disorders, including cardiovascular disease (CVD), obesity, diabetes, and cerebrovascular disease. Low-density lipoprotein cholesterol (LDL-C) currently remains the primary target for treatment of hyperlipidemia. Despite the advancement of treatment and prevention of hyperlipidemia, medications used to manage hyperlipidemia are limited to allopathic drugs, which present certain limitations and adverse effects. Increasing evidence indicates that utilization of phytochemicals and plant-based whole foods is an alternative and promising strategy to prevent hyperlipidemia and CVD. The current review focuses on phytochemicals and their pharmacological mode of actions for the regulation of LDL-C and prevention of CVD. The important molecular mechanisms illustrated in detail in this review include elevation of reverse cholesterol transport, inhibition of intestinal cholesterol absorption, acceleration of cholesterol excretion in the liver, and reduction of cholesterol synthesis. Moreover, the beneficial effects of plant-based whole foods, such as fresh fruits, vegetables, dried nuts, flax seeds, whole grains, peas, beans, vegan diets, and dietary fibers in LDL-C reduction and cardiovascular health are summarized. This review concludes that phytochemicals and plant-based whole foods can reduce LDL-C levels and lower the risk for CVD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. An Update on the Role of Dietary Phytochemicals in Human Skin Cancer: New Insights into Molecular Mechanisms.
- Author
-
Islam, Salman Ul, Ahmed, Muhammad Bilal, Ahsan, Haseeb, Islam, Mazharul, Shehzad, Adeeb, Sonn, Jong Kyung, and Lee, Young Sup
- Subjects
SKIN cancer ,PHYTOCHEMICALS ,FREE radicals ,CANCER invasiveness ,CYCLIN-dependent kinase inhibitor-2A - Abstract
Human skin is continuously subjected to environmental stresses, as well as extrinsic and intrinsic noxious agents. Although skin adopts various molecular mechanisms to maintain homeostasis, excessive and repeated stresses can overwhelm these systems, leading to serious cutaneous damage, including both melanoma and non-melanoma skin cancers. Phytochemicals present in the diet possess the desirable effects of protecting the skin from damaging free radicals as well as other benefits. Dietary phytochemicals appear to be effective in preventing skin cancer and are inexpensive, widely available, and well tolerated. Multiple in vitro and in vivo studies have demonstrated the significant anti-inflammatory, antioxidant, and anti-angiogenic characteristics of dietary phytochemicals against skin malignancy. Moreover, dietary phytochemicals affect multiple important cellular processes including cell cycle, angiogenesis, and metastasis to control skin cancer progression. Herein, we discuss the advantages of key dietary phytochemicals in whole fruits and vegetables, their bioavailability, and underlying molecular mechanisms for preventing skin cancer. Current challenges and future prospects for research are also reviewed. To date, most of the chemoprevention investigations have been conducted preclinically, and additional clinical trials are required to conform and validate the preclinical results in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
- Author
-
Islam, Salman Ul, Shehzad, Adeeb, Ahmed, Muhammad Bilal, Lee, Young Sup, de la Fuente, Jesús Martínez, and Asín, Laura
- Subjects
BLOOD-brain barrier ,NEUROLOGICAL disorders ,TARGETED drug delivery ,INTRANASAL medication ,ALZHEIMER'S disease ,PARKINSON'S disease - Abstract
Although the global prevalence of neurological disorders such as Parkinson's disease, Alzheimer's disease, glioblastoma, epilepsy, and multiple sclerosis is steadily increasing, effective delivery of drug molecules in therapeutic quantities to the central nervous system (CNS) is still lacking. The blood brain barrier (BBB) is the major obstacle for the entry of drugs into the brain, as it comprises a tight layer of endothelial cells surrounded by astrocyte foot processes that limit drugs' entry. In recent times, intranasal drug delivery has emerged as a reliable method to bypass the BBB and treat neurological diseases. The intranasal route for drug delivery to the brain with both solution and particulate formulations has been demonstrated repeatedly in preclinical models, including in human trials. The key features determining the efficacy of drug delivery via the intranasal route include delivery to the olfactory area of the nares, a longer retention time at the nasal mucosal surface, enhanced penetration of the drugs through the nasal epithelia, and reduced drug metabolism in the nasal cavity. This review describes important neurological disorders, challenges in drug delivery to the disordered CNS, and new nasal delivery techniques designed to overcome these challenges and facilitate more efficient and targeted drug delivery. The potential for treatment possibilities with intranasal transfer of drugs will increase with the development of more effective formulations and delivery devices. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Potential applications of bacterial cellulose and its composites for cancer treatment.
- Author
-
Islam, Salman Ul, Ul-Islam, Mazhar, Ahsan, Haseeb, Ahmed, Muhammad Bilal, Shehzad, Adeeb, Fatima, Atiya, Sonn, Jong Kyung, and Lee, Young Sup
- Subjects
- *
CANCER treatment , *BLOOD substitutes , *CELLULOSE , *CANCER cell growth , *CANCER cell culture , *MORPHOGENESIS , *NANOMEDICINE , *PLANT cell walls - Abstract
Bacterial cellulose (BC) has received immense interest in medical, pharmaceutical, and other related fields owing to its intrinsic physical, mechanical, and biological features. Its structural features offer an ideal environment for developing composites, thereby further extending its areas of applications. BC was initially used in wound dressing, artificial blood vessels, organ development, and tissue regeneration; however, the recent focus has switched to 3D printing techniques. BC can serve as suitable material for treating different cancers due to unique liquid absorbing and drug loading properties. BC-based scaffolds have been synthesized and tested for in vitro culturing of cancer cells to simulate tumor microenvironments. These scaffolds support normal growth of cancer cells, particularly breast and ovarian cancer cells, showing significant adhesion, proliferation, ingrowth, and differentiation. This review describes the different approaches of manipulating BC for use in medicine, with particular focus on the applications of BC composites in cancer treatment. A detailed discussion about various formulations of BC in multiple cancer therapeutics is summarized. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. The Complex Roles of DNA Repair Pathways, Inhibitors, Hyperthermia, and Contact Inhibition in Cell Cycle Halts.
- Author
-
Ahmed MB, Alghamdi AAA, Islam SU, Ahsan H, and Lee YS
- Subjects
- Contact Inhibition, G2 Phase Cell Cycle Checkpoints, Cell Line, Tumor, Cell Cycle, Cell Division, DNA Repair, DNA Damage, DNA, Apoptosis, Hyperthermia, Induced
- Abstract
The cell cycle has the capacity to safeguard the cell's DNA from damage. Thus, cell cycle arrest can allow tumor cells to investigate their own DNA repair processes. Cancer cells become extremely reliant on G1-phase cyclin-dependent kinases due to mutated oncogenes and deactivated tumor suppressors, producing replication stress and DNA damage during the S phase and destroying checkpoints that facilitate progression through the S/G2/M phase. DNA damage checkpoints activate DNA repair pathways to prevent cell proliferation, which occurs when the genome is damaged. However, research on how cells recommence division after a DNA lesion-induced arrest is insufficient which is merely the result of cancer cells' susceptibility to cell cycle arrest. For example, defects in the G1 arrest checkpoint may cause a cancer cell to proliferate more aggressively, and attempts to fix these complications may cause the cell to grow more slowly and eventually die. Defects in the G2-M arrest checkpoint may enable a damaged cell to enter mitosis and suffer apoptosis, and attempts to boost the effectiveness of chemotherapy may increase its cytotoxicity. Alternatively, attempts to promote G2-M arrest have also been linked to increased apoptosis in the laboratory. Furthermore, variables, such as hyperthermia, contact inhibition, nucleotide shortage, mitotic spindle damage, and resting phase effects, and DNA replication inhibitors add together to halt the cell cycle. In this review, we look at how nucleotide excision repair, MMR, and other variables, such as DNA replication inhibitors, hyperthermia, and contact inhibition, contribute to the outlined processes and functional capacities that cause cell cycle arrest., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2023
- Full Text
- View/download PDF
24. Comparison of Fentanyl and Dexmedetomidine in Preventing an Increase in Heart Rate During Intubation Among Patients Undergoing General Anesthesia: A Meta-Analysis.
- Author
-
Mohsin S, Ahmad Ganaie Z, Kundi H, Ahmed MB, Riaz B, Khurshid Ahmed N, Anirudh Chunchu V, and Haq A
- Abstract
General anesthesia induction, tracheal intubation, extubation, and laryngoscopy are associated with specific hemodynamic changes. Tracheal intubation and laryngoscopy are related to sympathetic stimulation and lead to hypertension and tachycardia. Recent studies have shown that dexmedetomidine is safe and effective as it does not depress respiratory function. This meta-analysis aims to compare the efficacy of dexmedetomidine and fentanyl in preventing an increase in heart rate (HR) during intubation among patients undergoing general anesthesia. A systematic literature search was done using PubMed, Cochrane Library, and Embase to assess studies comparing the efficacy of dexmedetomidine and fentanyl in preventing an increase in HR during intubation. A meta-analysis was done utilizing a random-effects model, and mean differences of HR were determined between fentanyl and dexmedetomidine at baseline, one minute, five minutes, and 10 minutes of intubation. In this meta-analysis, eight randomized control trials were included, involving 548 patients (274 in the fentanyl group and 274 in the dexmedetomidine group). The findings showed that significant difference of HR was significantly lower in the dexmedetomidine group than the fentanyl group at one minute of intubation (mean difference = -8.46; P-value = 0.003), at five minutes of intubation (mean difference = -7.51; P-value = 0.001), and at 10 minutes of intubation (mean difference = -5.15; P-value = 0.030). In the current meta-analysis, dexmedetomidine was better than fentanyl in preventing tachycardia following endotracheal intubation. HR was significantly lower at one minute, five minutes, and 10 minutes after intubation in the dexmedetomidine group compared to the fentanyl group., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2022, Mohsin et al.)
- Published
- 2022
- Full Text
- View/download PDF
25. PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells.
- Author
-
Ahmed MB, Islam SU, Sonn JK, and Lee YS
- Subjects
- Actin Cytoskeleton genetics, Actin Cytoskeleton metabolism, Animals, Apoptosis drug effects, Cadherins genetics, Cadherins metabolism, Catalytic Domain, Colorectal Neoplasms genetics, HCT116 Cells, Humans, Male, Mice, Mice, Inbred BALB C, Mice, Nude, Oxidative Stress drug effects, Oxidative Stress genetics, Protein Serine-Threonine Kinases genetics, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Reactive Oxygen Species metabolism, Real-Time Polymerase Chain Reaction, Ribonucleoprotein, U4-U6 Small Nuclear genetics, Up-Regulation, Xenograft Model Antitumor Assays, Apoptosis genetics, Colorectal Neoplasms metabolism, Curcumin pharmacology, Drug Resistance, Neoplasm genetics, Epithelial-Mesenchymal Transition genetics, Protein Serine-Threonine Kinases metabolism, Ribonucleoprotein, U4-U6 Small Nuclear metabolism
- Abstract
We have investigated the involvement of the pre-mRNA processing factor 4B (PRP4) kinase domain in mediating drug resistance. HCT116 cells were treated with curcumin, and apoptosis was assessed based on flow cytometry and the generation of reactive oxygen species (ROS). Cells were then transfected with PRP4 or pre-mRNA-processing-splicing factor 8 (PRP8), and drug resistance was analyzed both in vitro and in vivo . Furthermore, we deleted the kinase domain in PRP4 using Gateway
TM technology. Curcumin induced cell death through the production of ROS and decreased the activation of survival signals, but PRP4 overexpression reversed the curcumin-induced oxidative stress and apoptosis. PRP8 failed to reverse the curcumin-induced apoptosis in the HCT116 colon cancer cell line. In xenograft mouse model experiments, curcumin effectively reduced tumour size whereas PRP4 conferred resistance to curcumin, which was evident from increasing tumour size, while PRP8 failed to regulate the curcumin action. PRP4 overexpression altered the morphology, rearranged the actin cytoskeleton, triggered epithelial-mesenchymal transition (EMT), and decreased the invasiveness of HCT116 cells. The loss of E-cadherin, a hallmark of EMT, was observed in HCT116 cells overexpressing PRP4. Moreover, we observed that the EMT-inducing potential of PRP4 was aborted after the deletion of its kinase domain. Collectively, our investigations suggest that the PRP4 kinase domain is responsible for promoting drug resistance to curcumin by inducing EMT. Further evaluation of PRP4-induced inhibition of cell death and PRP4 kinase domain interactions with various other proteins might lead to the development of novel approaches for overcoming drug resistance in patients with colon cancer.- Published
- 2020
- Full Text
- View/download PDF
26. Significance of Green Synthetic Chemistry from a Pharmaceutical Perspective.
- Author
-
Ahsan H, Islam SU, Ahmed MB, Lee YS, and Sonn JK
- Subjects
- Commerce, Humans, Solvents, Drug Industry, Pharmaceutical Preparations
- Abstract
Background: Conventional practices of synthesis, manufacturing, and processing have led to severe adverse consequences for living beings and the environment., Objectives: Although medications cannot be replaced, the methods of synthesizing, manufacturing, and processing them can be changed and/or replaced. This paper explains the significance of green chemistry practices in the pharmaceutical industry. It emphasizes that we must replace conventional drug synthesis, processing, and manufacturing techniques with greener ones that are cost-effective, sustainable, environment-friendly, and profitable., Discussion: This paper comprises five sections. Section 1 is an introduction to green chemistry and its correlation with the pharmaceutical industry. Section 2 discusses the metrics necessary to measure the greenness of a process. Section 3 is about solvents used in the pharmaceutical industry, hazards, safety status, and environmental effects, including the ozone depletion potential. Section 4 explains catalytic amidation reactions because amides are one of the most commonly occurring functional groups with pharmacological activity. Section 5 discusses successful cases of converting conventional synthesis of active pharmaceutical ingredients and/or their intermediates to greener, sustainable alternatives., Conclusion: A balance is necessary between profits, processes, consumers, and the environment to ensure the survival of all stakeholders and decrease the environmental burden of pharmaceuticals. Incentives such as green chemistry awards should be endorsed and encouraged, in addition to making green chemistry part of tertiary education. In addition, changes to rules and regulations for drug approval in the context of green chemistry principles are necessary in order to preserve our planet for future generations., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
27. Concomitant Drug Treatment and Elimination in the RCC-affected Kidneys: Can We Kill Two Birds with One Stone?
- Author
-
Ahmed MB, Salman Ul Islam, and Lee YS
- Subjects
- Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Renal Cell complications, Carcinoma, Renal Cell pathology, Carcinoma, Renal Cell physiopathology, Clinical Trials as Topic, Dose-Response Relationship, Drug, Drug Interactions, Glomerular Filtration Rate physiology, Humans, Kidney pathology, Kidney Neoplasms complications, Kidney Neoplasms pathology, Kidney Neoplasms physiopathology, Molecular Targeted Therapy methods, Renal Elimination physiology, Renal Insufficiency etiology, Vascular Endothelial Growth Factor A antagonists & inhibitors, Antineoplastic Combined Chemotherapy Protocols pharmacokinetics, Carcinoma, Renal Cell drug therapy, Kidney physiopathology, Kidney Neoplasms drug therapy, Renal Insufficiency physiopathology
- Abstract
Background: The kidneys are vital organs acting as the body's filters that eliminate drugs and other waste products from the body. For effective cancer therapy, a delicate balance is required in the drug treatment and its elimination, which is critical for drug accumulation, toxicity, and kidney malfunction. However, how renal cell carcinoma (RCC) affects the kidneys in safely eliminating the byproducts of drug treatments in patients with severely dysregulated kidney functions had remained elusive. Recent advancements in dose adjustment have added to our understanding regarding how drug treatments could be effectively regulated in aberrant kidney cells, driving safe elimination and reducing drug accumulation and toxicity at the right time and space. Dose adjustment is the only standard systemic way applicable; however, it presents certain limitations. There is significant room for developing new strategies and alternatives to improve it., Objectives: Our analysis of the available treatments in literature discusses the treatment and their safe eliminations. In this study, we give an overview of the measures that could be taken to maintain the elimination gradient of anti-cancer drugs and restore normal kidney function in RCC. Differential therapeutics of RCC/mRCC in various clinical phase trials and the interaction of targeted therapeutics in response to vascular endothelial growth factor (VEGF) were also discussed., Conclusion: Such information might suggest a new direction in controlling treatment with safe elimination through dose adjustment and its associated alternatives in a judicious manner. A strategy to systematically focus on the safe elimination of anti-cancer drugs in RCC strongly needs advocating., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
28. Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?
- Author
-
Ul-Islam S, Ahmed MB, Shehzad A, Ul-Islam M, and Lee YS
- Subjects
- Carcinoma, Hepatocellular therapy, Humans, Liver enzymology, Liver metabolism, Liver Neoplasms therapy, Membrane Transport Proteins metabolism, Antineoplastic Agents therapeutic use, Carcinoma, Hepatocellular drug therapy, Drug Resistance, Neoplasm, Liver Neoplasms drug therapy
- Abstract
Background: Most of the drugs are metabolized in the liver by the action of drug metabolizing enzymes. In hepatocellular carcinoma (HCC), primary drug metabolizing enzymes are severely dysregulated, leading to failure of chemotherapy. Sorafenib is the only standard systemic drug available, but it still presents certain limitations, and much effort is required to understand who is responsive and who is refractory to the drug. Preventive and therapeutic approaches other than systemic chemotherapy include vaccination, chemoprevention, liver transplantation, surgical resection, and locoregional therapies., Objectives: This review details the dysregulation of primary drug metabolizing enzymes and drug transport proteins of the liver in HCC and their influence on chemotherapeutic drugs. Furthermore, it emphasizes the adoption of safe alternative therapeutic strategies to chemotherapy., Conclusion: The future of HCC treatment should emphasize on understanding of resistance mechanisms and the finding of novel, safe, and efficacious therapeutic strategies, which will surely benefit patients affected by advanced HCC., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.